hotspot -WSS

hotspot

author：fashion 2025-09-30 12:17:23 - browse：963

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Why did Pfizer dish out millions for a Super Bowl ad?

WSS

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Readout LOUD podcast: How biotech is using artificial intelligence

Russian court extends detention of American musician

Readout LOUD podcast: How biotech is using artificial intelligence

hotspot

hotspot

leisure time

New air purifier tech could be key to improving indoor air quality

Calls for Trump's election interference trial to be televised part of long debate

Trump demands the U.S. pay no more for drugs than other countries … again

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

At least 13 dead in Texas as scorching temps continue

'Revelatory' study finds a smoking impact that remains after quitting

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

KalVista pill reduced swelling 'attacks' caused by genetic disease

explore

Medicare Advantage proposed rates disappoint insurers

Medical mystery: When an infection after surgery isn’t what it seems

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Eat, drink, but be wary — 4 foods that interact with medications

What we’ve learned from the Aduhelm mess

Climate activists disrupt London Pride march to protest corporate sponsorship

hotspot

knowledge

hotspot

hotspot